1. 1955. Immunogenicity And Safety of a Virus-Like Particle (VLP) Protein Subunit SARS-CoV-2 Vaccine in Adults: a Phase 1/2 Study. (15th December 2022) Authors: Scott, Robert; Thackwray, Susan; Hourguettes, Nicholas; Gelderblom, Huub; Kanesa-thasan, Niranjan Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of a universal influenza A vaccine (MVA-NP+M1) in adults when given after seasonal quadrivalent influenza vaccine immunisation (FLU009): a phase 2b, randomised, double-blind trial. Issue 6 (June 2022) Authors: Evans, Thomas G; Bussey, Louise; Eagling-Vose, Elizabeth; Rutkowski, Kathryn; Ellis, Chris; Argent, Chris; Griffin, Paul; Kim, Joshua; Thackwray, Susan; Shakib, Sepehr; Doughty, Julia; Gillies, John; Wu, Jian; Druce, Julian; Pryor, Melinda; Gilbert, Sarah Journal: Lancet infectious diseases Issue: Volume 22:Issue 6(2022) Page Start: 857 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial. Issue 11 (November 2022) Authors: Mallory, Raburn M; Formica, Neil; Pfeiffer, Susan; Wilkinson, Bethanie; Marcheschi, Alex; Albert, Gary; McFall, Heather; Robinson, Michelle; Plested, Joyce S; Zhu, Mingzhu; Cloney-Clark, Shane; Zhou, Bin; Chau, Gordon; Robertson, Andreana; Maciejewski, Sonia; Hammond, Holly L; Baracco, Lauren; Lo... Journal: Lancet infectious diseases Issue: Volume 22:Issue 11(2022) Page Start: 1565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗